Innovative
solutions
in nuclear
medicine

With over 30 years of experience in the field of nuclear and respiratory medicine, Cyclomedica continues to enhance and develop medical innovations.

Of significant interest, when compared to CT, is the low radiation dose imparted by V/Q SPECT imaging.

Proprietary radiopharmaceutical technologies designed to improve patient outcomes every day.

With sales to over 60 countries throughout the world, Cyclomedica delivers its products through a range of partnerships.

Cyclopharm is a radiopharmaceutical company servicing the global medical community since 1986.